arrow
E

Edoardo Crimini

irccs european institute of oncology
H指数:14
被引数:810

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Oral selective estrogen receptor degraders (SERDs) for the treatment of hormone receptor-positive, HER2-negative breast cancer title

口服选择性雌激素受体降解剂(SERDs)用于治疗激素受体阳性、HER2阴性乳腺癌

2026-05-011
PRE
Genomically matched therapy in advanced solid tumors: the randomized phase 2 ROME trial

基因组匹配疗法在晚期实体瘤中的应用:随机II期ROME试验

2025-09-290
OAAI
Molecular tumor board in patients with metastatic breast cancer

转移性乳腺癌患者的分子肿瘤板

2024-10-301
PRE
A SET OF EASY AND STRINGENT CRITERIA TO IDENTIFY IMMUNE-RELATED ADVERSE EVENTS (IRAE SCORING SYSTEM, ISS) IMPROVES CORRELATION WITH OUTCOME IN A PHASE 1-2 TRIAL POPULATION
2022-11-070
OA